High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study
We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of the observational German Epidemiological Trial on Ankle Brachial Index (getABI study), 344 general practitione...
Saved in:
Published in | Atherosclerosis Vol. 172; no. 1; pp. 95 - 105 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier Ireland Ltd
2004
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 0021-9150 |
DOI | 10.1016/S0021-9150(03)00204-1 |
Cover
Abstract | We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of the observational German Epidemiological Trial on Ankle Brachial Index (getABI study), 344 general practitioners throughout Germany determined the ABI of consecutive, unselected patients aged 65 years or older with bilateral Doppler ultrasound measurements. Additional assessments comprised patient history with the focus on atherothrombotic diseases, physical examination, and the WHO questionnaire on intermittent claudication. A total of 6880 patients were included (42.0% male, mean age 72.5 years, mean body mass index 27.3 kg/m
2, mean systolic/diastolic blood pressure 143.7/81.3 mmHg). The prevalence of PAD for men/women as indicated by an ankle brachial index (AB1)<0.9 was 19.8/16.8%. Patients with PAD were slightly older than patients without PAD, suffered more frequently from diabetes (36.6 vs. 22.6%; adjusted OR: 1.8), hypertension (78.8 vs. 61.6%; OR: 2.2), lipid disorders (57.2 vs. 50.7%; OR: 1.3) and other coexisting atherothrombotic diseases (any cerebrovascular event: 15.0 vs. 7.6%; OR: 1.8; any cardiovascular event: 28.9 vs. 17.0%; OR: 1.5). The data highlight the high prevalence of PAD in primary care. PAD patients are characterised by a high co-morbidity, particularly with regard to other manifestations of atherothrombosis. Doppler ultrasound measurement for ABI determinations is a non-invasive, inexpensive, reliable tool in primary care and enables GPs to identify patients at risk of PAD. |
---|---|
AbstractList | We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of the observational German Epidemiological Trial on Ankle Brachial Index (getABI study), 344 general practitioners throughout Germany determined the ABI of consecutive, unselected patients aged 65 years or older with bilateral Doppler ultrasound measurements. Additional assessments comprised patient history with the focus on atherothrombotic diseases, physical examination, and the WHO questionnaire on intermittent claudication. A total of 6880 patients were included (42.0% male, mean age 72.5 years, mean body mass index 27.3 kg/m(2), mean systolic/diastolic blood pressure 143.7/81.3 mmHg). The prevalence of PAD for men/women as indicated by an ankle brachial index (AB1)<0.9 was 19.8/16.8%. Patients with PAD were slightly older than patients without PAD, suffered more frequently from diabetes (36.6 vs. 22.6%; adjusted OR: 1.8), hypertension (78.8 vs. 61.6%; OR: 2.2), lipid disorders (57.2 vs. 50.7%; OR: 1.3) and other coexisting atherothrombotic diseases (any cerebrovascular event: 15.0 vs. 7.6%; OR: 1.8; any cardiovascular event: 28.9 vs. 17.0%; OR: 1.5). The data highlight the high prevalence of PAD in primary care. PAD patients are characterised by a high co-morbidity, particularly with regard to other manifestations of atherothrombosis. Doppler ultrasound measurement for ABI determinations is a non-invasive, inexpensive, reliable tool in primary care and enables GPs to identify patients at risk of PAD. We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of the observational German Epidemiological Trial on Ankle Brachial Index (getABI study), 344 general practitioners throughout Germany determined the ABI of consecutive, unselected patients aged 65 years or older with bilateral Doppler ultrasound measurements. Additional assessments comprised patient history with the focus on atherothrombotic diseases, physical examination, and the WHO questionnaire on intermittent claudication. A total of 6880 patients were included (42.0% male, mean age 72.5 years, mean body mass index 27.3 kg/m(2), mean systolic/diastolic blood pressure 143.7/81.3 mmHg). The prevalence of PAD for men/women as indicated by an ankle brachial index (AB1)<0.9 was 19.8/16.8%. Patients with PAD were slightly older than patients without PAD, suffered more frequently from diabetes (36.6 vs. 22.6%; adjusted OR: 1.8), hypertension (78.8 vs. 61.6%; OR: 2.2), lipid disorders (57.2 vs. 50.7%; OR: 1.3) and other coexisting atherothrombotic diseases (any cerebrovascular event: 15.0 vs. 7.6%; OR: 1.8; any cardiovascular event: 28.9 vs. 17.0%; OR: 1.5). The data highlight the high prevalence of PAD in primary care. PAD patients are characterised by a high co-morbidity, particularly with regard to other manifestations of atherothrombosis. Doppler ultrasound measurement for ABI determinations is a non-invasive, inexpensive, reliable tool in primary care and enables GPs to identify patients at risk of PAD.We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of the observational German Epidemiological Trial on Ankle Brachial Index (getABI study), 344 general practitioners throughout Germany determined the ABI of consecutive, unselected patients aged 65 years or older with bilateral Doppler ultrasound measurements. Additional assessments comprised patient history with the focus on atherothrombotic diseases, physical examination, and the WHO questionnaire on intermittent claudication. A total of 6880 patients were included (42.0% male, mean age 72.5 years, mean body mass index 27.3 kg/m(2), mean systolic/diastolic blood pressure 143.7/81.3 mmHg). The prevalence of PAD for men/women as indicated by an ankle brachial index (AB1)<0.9 was 19.8/16.8%. Patients with PAD were slightly older than patients without PAD, suffered more frequently from diabetes (36.6 vs. 22.6%; adjusted OR: 1.8), hypertension (78.8 vs. 61.6%; OR: 2.2), lipid disorders (57.2 vs. 50.7%; OR: 1.3) and other coexisting atherothrombotic diseases (any cerebrovascular event: 15.0 vs. 7.6%; OR: 1.8; any cardiovascular event: 28.9 vs. 17.0%; OR: 1.5). The data highlight the high prevalence of PAD in primary care. PAD patients are characterised by a high co-morbidity, particularly with regard to other manifestations of atherothrombosis. Doppler ultrasound measurement for ABI determinations is a non-invasive, inexpensive, reliable tool in primary care and enables GPs to identify patients at risk of PAD. We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of the observational German Epidemiological Trial on Ankle Brachial Index (getABI study), 344 general practitioners throughout Germany determined the ABI of consecutive, unselected patients aged 65 years or older with bilateral Doppler ultrasound measurements. Additional assessments comprised patient history with the focus on atherothrombotic diseases, physical examination, and the WHO questionnaire on intermittent claudication. A total of 6880 patients were included (42.0% male, mean age 72.5 years, mean body mass index 27.3 kg/m 2, mean systolic/diastolic blood pressure 143.7/81.3 mmHg). The prevalence of PAD for men/women as indicated by an ankle brachial index (AB1)<0.9 was 19.8/16.8%. Patients with PAD were slightly older than patients without PAD, suffered more frequently from diabetes (36.6 vs. 22.6%; adjusted OR: 1.8), hypertension (78.8 vs. 61.6%; OR: 2.2), lipid disorders (57.2 vs. 50.7%; OR: 1.3) and other coexisting atherothrombotic diseases (any cerebrovascular event: 15.0 vs. 7.6%; OR: 1.8; any cardiovascular event: 28.9 vs. 17.0%; OR: 1.5). The data highlight the high prevalence of PAD in primary care. PAD patients are characterised by a high co-morbidity, particularly with regard to other manifestations of atherothrombosis. Doppler ultrasound measurement for ABI determinations is a non-invasive, inexpensive, reliable tool in primary care and enables GPs to identify patients at risk of PAD. |
Author | Schuster, Alexander Diehm, Curt Allenberg, Jens R. Tepohl, Gerhart Trampisch, Hans-Joachim von Stritzky, Berndt Darius, Harald Lange, Stefan Pittrow, David Haberl, Roman |
Author_xml | – sequence: 1 givenname: Curt surname: Diehm fullname: Diehm, Curt email: curt.diehm@kkl.srh.de organization: Department of Internal Medicine, Vascular Medicine, Affiliated Teaching Hospital, University of Heidelberg, Guttmannstr. 1, D-76307 Karlsbad, Germany – sequence: 2 givenname: Alexander surname: Schuster fullname: Schuster, Alexander organization: 3P Consulting, D-82393 Pöcking, Germany – sequence: 3 givenname: Jens R. surname: Allenberg fullname: Allenberg, Jens R. organization: Department of Vascular Surgery, Section for Vascular Surgery, Ruprecht-Karls University of Heidelberg, D-69120 Heidelberg, Germany – sequence: 4 givenname: Harald surname: Darius fullname: Darius, Harald organization: Department of Medicine, Klinikum Berlin-Neukölln, Vivantes Netzwerk für Gesundheit, D-12313 Berlin, Germany – sequence: 5 givenname: Roman surname: Haberl fullname: Haberl, Roman organization: Department of Neurology, Städtisches Krankenhaus München-Harlaching, D-81545 Munich, Germany – sequence: 6 givenname: Stefan surname: Lange fullname: Lange, Stefan organization: Department of Medical Informatics, Biometry and Epidemiology, Ruhr University Bochum, D-44780 Bochum, Germany – sequence: 7 givenname: David surname: Pittrow fullname: Pittrow, David organization: Department of Clinical Pharmacology, Medical Faculty, Technical University of Dresden, D-01307 Dresden, Germany – sequence: 8 givenname: Berndt surname: von Stritzky fullname: von Stritzky, Berndt organization: Medical Department, Sanofi-Synthelabo, D-10785 Berlin, Germany – sequence: 9 givenname: Gerhart surname: Tepohl fullname: Tepohl, Gerhart organization: Practice for Vascular Medicine, D-80336 Munich, Germany – sequence: 10 givenname: Hans-Joachim surname: Trampisch fullname: Trampisch, Hans-Joachim organization: Department of Medical Informatics, Biometry and Epidemiology, Ruhr University Bochum, D-44780 Bochum, Germany |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15383525$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/14709362$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUtv1TAQhb0oog_4CSBvQLAIjOM4cUAIoQooUiUWwNpy7AkdyHVS27fS_ff4PqBSN2Vh2WN950hzzik7CnNAxp4IeCVAtK-_AdSi6oWCFyBflgGaShyxk3_fx-w0pV8A0HRCP2THoumgl219wvIF_bziS8QbO2FwyOeRLxhpucJoJ25jLkN5eEpoE3IbPHdztZrjQJ7yhlPgrdZQLGhl44Y7G5EvNhOGnN5wF-eUqoQu0xyKT8prv3nEHox2Svj4cJ-xH58-fj-_qC6_fv5y_uGyckqIXHVet4Ps3SDAjiDrXksA34tyagFoXaMH1dbYKT0iyk6qseuHtpd9J1xjR3nGnu99lzhfrzFls6LkcJpswHmdjAbQstVNAZ8ewPWwQm8Oy5i_ORXg2QGwydlpjDY4SrecklqqWhVO7bnd3hHHWwTMtiuz68psSzEgza4rI4ru7R2do2y3meVoabpX_X6vxhLmDWE0ydG2TU-xJG_8TPc6vLvj4CYKVFb9jZv_0P8BK2nBtw |
CitedBy_id | crossref_primary_10_1111_j_1538_7836_2006_02225_x crossref_primary_10_2214_AJR_19_21520 crossref_primary_10_1007_s10389_018_0898_4 crossref_primary_10_1038_nrrheum_2012_16 crossref_primary_10_3109_08037051_2010_491178 crossref_primary_10_1191_1358863x05vm591xx crossref_primary_10_1016_j_jpain_2008_09_001 crossref_primary_10_1016_S2255_4823_12_70248_5 crossref_primary_10_1007_s00103_017_2676_9 crossref_primary_10_1038_hr_2012_83 crossref_primary_10_1253_circj_71_95 crossref_primary_10_1016_j_jacc_2017_03_024 crossref_primary_10_5758_kjves_2011_27_4_168 crossref_primary_10_1007_s00772_005_0409_0 crossref_primary_10_1007_s12602_023_10191_2 crossref_primary_10_1016_j_angio_2013_01_012 crossref_primary_10_1016_j_mri_2022_08_001 crossref_primary_10_1583_04_1449_1 crossref_primary_10_1016_j_apmr_2005_11_025 crossref_primary_10_2169_internalmedicine_49_3884 crossref_primary_10_1016_j_jvs_2009_08_085 crossref_primary_10_1111_j_1600_0404_2006_00725_x crossref_primary_10_1016_S0304_5412_09_73019_7 crossref_primary_10_1111_j_1747_4949_2010_00440_x crossref_primary_10_1007_s12055_013_0246_9 crossref_primary_10_1111_all_12354 crossref_primary_10_1007_s00772_013_1178_9 crossref_primary_10_1002_jmri_23944 crossref_primary_10_2337_dc08_1639 crossref_primary_10_1016_j_ejrad_2012_12_021 crossref_primary_10_1007_s00330_012_2625_9 crossref_primary_10_1136_bmjopen_2021_057630 crossref_primary_10_1093_eurheartj_eht288 crossref_primary_10_1016_j_yasu_2009_02_002 crossref_primary_10_1016_j_atherosclerosis_2008_05_046 crossref_primary_10_15656_kjcg_2022_23_1_9 crossref_primary_10_1007_s10856_015_5506_3 crossref_primary_10_1016_j_jdiacomp_2007_06_011 crossref_primary_10_1016_j_pain_2006_04_011 crossref_primary_10_3390_jcm12134411 crossref_primary_10_3390_ijms231810481 crossref_primary_10_1007_s00117_009_1911_2 crossref_primary_10_1007_s00772_012_1109_1 crossref_primary_10_1007_s00772_020_00736_y crossref_primary_10_1007_s00772_021_00786_w crossref_primary_10_1007_s00115_007_2305_1 crossref_primary_10_1136_bmjopen_2021_054352 crossref_primary_10_1007_s11428_008_0338_0 crossref_primary_10_1038_jhh_2013_99 crossref_primary_10_1007_s15006_018_0002_6 crossref_primary_10_4078_jrd_2012_19_1_63 crossref_primary_10_1002_ccd_21401 crossref_primary_10_1007_s00270_017_1674_5 crossref_primary_10_1016_j_ejvs_2009_11_007 crossref_primary_10_3390_jcm11082155 crossref_primary_10_1016_j_jstrokecerebrovasdis_2011_08_011 crossref_primary_10_1177_15266028060130S205 crossref_primary_10_1161_CIR_0b013e31822e80c3 crossref_primary_10_1002_jmri_21540 crossref_primary_10_1111_iwj_12003 crossref_primary_10_1002_14651858_CD001368_pub4 crossref_primary_10_1371_journal_pone_0167408 crossref_primary_10_1016_j_acvfr_2011_11_012 crossref_primary_10_1055_a_1771_0056 crossref_primary_10_1186_1745_6215_13_215 crossref_primary_10_1016_j_ejvs_2011_08_014 crossref_primary_10_1177_1526602819849955 crossref_primary_10_1016_j_ccl_2005_03_006 crossref_primary_10_1097_SLA_0000000000006375 crossref_primary_10_1016_j_angio_2015_04_013 crossref_primary_10_1185_03007990903223895 crossref_primary_10_3238_arztebl_2020_0188 crossref_primary_10_1007_s00547_005_2055_5 crossref_primary_10_1186_s13293_022_00432_4 crossref_primary_10_1007_s00772_022_00922_0 crossref_primary_10_1016_j_atherosclerosis_2010_11_030 crossref_primary_10_1016_j_atherosclerosis_2021_09_022 crossref_primary_10_1016_j_jcin_2013_10_004 crossref_primary_10_1007_s00772_010_0784_z crossref_primary_10_1007_s00108_011_2814_7 crossref_primary_10_1016_j_acvfr_2011_11_020 crossref_primary_10_1016_j_avsg_2021_07_057 crossref_primary_10_1016_j_atherosclerosis_2022_10_002 crossref_primary_10_1111_j_1742_1241_2010_02337_x crossref_primary_10_1007_s00392_005_1406_8 crossref_primary_10_1007_BF03324882 crossref_primary_10_1016_j_avsg_2021_06_011 crossref_primary_10_1016_j_ejvs_2008_01_013 crossref_primary_10_1007_s00772_009_0693_1 crossref_primary_10_1016_j_ijge_2018_02_001 crossref_primary_10_1016_j_jvs_2007_11_056 crossref_primary_10_1007_BF03324767 crossref_primary_10_1007_s00270_007_9095_5 crossref_primary_10_1007_s13244_012_0180_1 crossref_primary_10_1016_j_ejvs_2005_11_022 crossref_primary_10_1177_0003319716677667 crossref_primary_10_1016_j_avsg_2015_11_009 crossref_primary_10_1093_eurheartj_ehac016 crossref_primary_10_2217_WHE_09_60 crossref_primary_10_1055_a_1679_6334 crossref_primary_10_1016_j_ejvs_2009_12_003 crossref_primary_10_1080_17446651_2016_1175936 crossref_primary_10_1016_j_athoracsur_2024_01_021 crossref_primary_10_1016_j_jvs_2020_06_104 crossref_primary_10_1016_j_jvs_2008_07_062 crossref_primary_10_1016_j_cpcardiol_2012_07_001 crossref_primary_10_23736_S0026_4806_22_07909_5 crossref_primary_10_1177_1358863X19883945 crossref_primary_10_1016_S0304_5412_09_73017_3 crossref_primary_10_23736_S0392_9590_19_04167_1 crossref_primary_10_1139_y2012_010 crossref_primary_10_1016_j_ehj_2018_06_005 crossref_primary_10_1016_j_jtumed_2016_01_010 crossref_primary_10_1016_j_ejvs_2013_04_006 crossref_primary_10_1007_s10389_008_0223_8 crossref_primary_10_1016_j_jvs_2009_08_051 crossref_primary_10_1007_s11095_005_6334_9 crossref_primary_10_1007_s00115_014_4125_4 crossref_primary_10_1007_s12181_021_00520_6 crossref_primary_10_1186_s12955_014_0171_7 crossref_primary_10_1002_jmri_21351 crossref_primary_10_1016_S1134_2072_09_71418_5 crossref_primary_10_1097_HJR_0b013e32831c1383 crossref_primary_10_1016_j_avsg_2022_02_009 crossref_primary_10_1007_s11428_008_0336_2 crossref_primary_10_7251_bii1902128l crossref_primary_10_1007_s00330_009_1607_z crossref_primary_10_1016_j_jvs_2006_02_019 crossref_primary_10_1177_1708538112472288 crossref_primary_10_12687_phleb2318_4_2016 crossref_primary_10_5339_gcsp_2013_13 crossref_primary_10_1055_a_1916_9717 crossref_primary_10_1177_1358863X15616687 crossref_primary_10_1007_s12181_012_0453_4 crossref_primary_10_1186_s12872_022_02751_1 crossref_primary_10_1007_s12055_015_0415_0 crossref_primary_10_1016_j_atherosclerosis_2021_03_019 crossref_primary_10_1186_1756_0500_6_404 crossref_primary_10_1177_0003319709348295 crossref_primary_10_1177_2048004020907002 crossref_primary_10_1016_j_jvs_2005_01_047 crossref_primary_10_1177_1358863X13483864 crossref_primary_10_1007_s00104_007_1367_8 crossref_primary_10_1111_j_1747_4949_2011_00752_x crossref_primary_10_1161_01_HYP_0000196686_85286_9c crossref_primary_10_1161_JAHA_122_026347 crossref_primary_10_1177_1359105315600238 crossref_primary_10_1157_13086042 crossref_primary_10_1007_s11739_011_0511_0 crossref_primary_10_3238_arztebl_2016_0729 crossref_primary_10_1024_0301_1526_a000700 crossref_primary_10_1016_j_jvs_2009_01_004 crossref_primary_10_1093_eurjcn_zvad044 crossref_primary_10_3238_arztebl_m2024_0008 crossref_primary_10_1007_s00270_005_0296_5 crossref_primary_10_1016_j_atherosclerosis_2004_02_001 crossref_primary_10_3238_arztebl_2008_0769 crossref_primary_10_1007_s12262_011_0364_9 crossref_primary_10_1007_s00415_007_0590_z crossref_primary_10_1016_j_avsg_2014_09_003 crossref_primary_10_1016_j_atherosclerosis_2004_02_002 crossref_primary_10_1007_s11739_012_0854_1 crossref_primary_10_1016_j_surge_2011_05_003 crossref_primary_10_1007_s00108_009_2365_3 crossref_primary_10_1007_s00270_017_1840_9 crossref_primary_10_1177_1358863X10378376 crossref_primary_10_1016_S1262_3636_07_80057_7 crossref_primary_10_9738_0020_8868_97_1_56 crossref_primary_10_3390_diagnostics11081407 crossref_primary_10_1590_1677_5449_20130092 crossref_primary_10_1016_j_jcct_2023_03_003 crossref_primary_10_1007_s00772_017_0326_z crossref_primary_10_1161_CIRCULATIONAHA_107_763227 crossref_primary_10_1016_j_cpcardiol_2009_05_001 crossref_primary_10_1016_j_atherosclerosis_2020_09_026 crossref_primary_10_1016_j_jvs_2014_02_059 crossref_primary_10_1024_0301_1526_a000954 crossref_primary_10_1024_0301_1526_a000834 crossref_primary_10_1177_0003319712439092 crossref_primary_10_17352_2455_5452_000033 crossref_primary_10_1007_s00772_020_00689_2 crossref_primary_10_1161_HYPERTENSIONAHA_110_169169 crossref_primary_10_1016_j_jvs_2016_02_059 crossref_primary_10_1016_j_atherosclerosis_2006_02_017 crossref_primary_10_1024_0301_1526_a000835 crossref_primary_10_1016_j_cca_2019_04_061 crossref_primary_10_1007_s00059_018_4774_3 crossref_primary_10_1016_j_ejvs_2005_09_006 crossref_primary_10_1016_S1634_7358_23_47940_5 crossref_primary_10_1016_j_acvd_2009_05_004 crossref_primary_10_1016_j_cll_2006_06_008 crossref_primary_10_1016_j_knee_2020_09_019 crossref_primary_10_1007_s15027_014_0379_9 crossref_primary_10_1016_j_ejim_2008_09_013 crossref_primary_10_1177_0260106018817190 crossref_primary_10_1111_1753_0407_12873 crossref_primary_10_1097_RLI_0b013e3182183a77 crossref_primary_10_1024_0301_1526_a000808 crossref_primary_10_1016_j_ejim_2011_02_001 crossref_primary_10_1177_1708538115592800 crossref_primary_10_1007_s00108_009_2366_2 crossref_primary_10_1016_j_acvfr_2010_12_011 crossref_primary_10_1007_s11606_010_1412_z crossref_primary_10_1007_s00772_010_0863_1 crossref_primary_10_1038_hr_2011_53 crossref_primary_10_1016_j_jacc_2011_08_023 crossref_primary_10_1080_13645706_2016_1190379 crossref_primary_10_1007_s12013_014_0043_0 crossref_primary_10_33546_bnj_742 crossref_primary_10_1024_0301_1526_a000810 crossref_primary_10_1016_j_cger_2019_07_009 crossref_primary_10_1186_1532_429X_15_14 crossref_primary_10_1371_journal_pone_0268201 crossref_primary_10_1186_s12245_022_00411_x crossref_primary_10_1002_ccd_21238 crossref_primary_10_4174_astr_2016_90_4_218 crossref_primary_10_1007_s00772_010_0787_9 crossref_primary_10_1016_j_avsg_2010_03_015 crossref_primary_10_1093_qjmed_hcn140 crossref_primary_10_1111_j_1524_4733_2006_00079_x crossref_primary_10_1007_s12170_011_0185_1 crossref_primary_10_3390_jcm12010097 crossref_primary_10_1016_S0214_9168_08_72576_2 crossref_primary_10_1177_1358863X20967091 crossref_primary_10_1583_05_1752_1 crossref_primary_10_1016_S0003_3170_07_75049_6 crossref_primary_10_1038_nrcardio_2011_66 crossref_primary_10_1007_s10554_021_02361_6 crossref_primary_10_1007_s00772_024_01136_2 crossref_primary_10_1080_00365513_2018_1497803 crossref_primary_10_1177_1755738015592043 crossref_primary_10_1038_s41598_021_84285_8 crossref_primary_10_1517_14728214_11_1_75 crossref_primary_10_1007_s15027_012_0328_4 crossref_primary_10_1016_j_ejvs_2005_01_001 crossref_primary_10_1016_j_pcd_2012_02_004 crossref_primary_10_1177_1534734607302238 crossref_primary_10_1371_journal_pone_0125032 crossref_primary_10_1016_j_jss_2020_03_030 crossref_primary_10_4093_dmj_2011_35_5_543 crossref_primary_10_1002_jmri_24463 crossref_primary_10_1016_j_jvs_2007_07_047 crossref_primary_10_1177_17085381221127051 crossref_primary_10_1016_j_atherosclerosis_2005_02_021 crossref_primary_10_1016_j_atherosclerosis_2014_08_032 crossref_primary_10_1016_j_ejvs_2006_03_007 crossref_primary_10_1024_0301_1526_a000969 crossref_primary_10_1111_j_1747_4949_2008_00220_x crossref_primary_10_1007_s11789_008_0046_8 crossref_primary_10_1024_0301_1526_a000728 crossref_primary_10_1007_s00108_009_2364_4 crossref_primary_10_1016_j_jvs_2012_10_115 crossref_primary_10_1016_S0828_282X_09_70021_2 crossref_primary_10_1007_s00482_007_0556_1 crossref_primary_10_1007_s00772_020_00740_2 crossref_primary_10_1016_j_avsg_2017_12_007 crossref_primary_10_1016_j_atherosclerosis_2004_09_003 crossref_primary_10_1016_j_jvs_2006_04_002 crossref_primary_10_29333_ejgm_12278 crossref_primary_10_1016_j_amjcard_2020_12_091 crossref_primary_10_5758_vsi_210072 crossref_primary_10_1080_14017430510035844 crossref_primary_10_1016_S0398_0499_04_96769_8 crossref_primary_10_1007_s00772_008_0595_7 crossref_primary_10_1016_j_jvs_2022_04_048 crossref_primary_10_33678_cor_2010_117 crossref_primary_10_1016_j_jvs_2018_05_225 crossref_primary_10_1016_j_ejvs_2006_04_029 crossref_primary_10_1016_j_ejvs_2014_08_025 crossref_primary_10_1016_j_jvs_2019_08_271 crossref_primary_10_2337_dc14_2900 crossref_primary_10_1007_s00104_004_0982_x crossref_primary_10_1007_s00132_009_1501_z crossref_primary_10_3390_ijms242417439 crossref_primary_10_1177_0003319708322923 crossref_primary_10_1016_j_jvs_2006_05_016 crossref_primary_10_1007_s11428_017_0283_x crossref_primary_10_1016_j_avsg_2018_05_070 crossref_primary_10_1186_1471_2261_11_59 crossref_primary_10_1111_j_1468_1331_2009_02874_x crossref_primary_10_2174_1573399815666190531093238 crossref_primary_10_1089_jwh_2013_4653 crossref_primary_10_1157_13128016 crossref_primary_10_1016_j_jvs_2009_03_008 crossref_primary_10_4236_ss_2019_107026 crossref_primary_10_1016_j_avsg_2025_03_007 crossref_primary_10_1016_j_carrev_2012_05_003 crossref_primary_10_1007_s13340_017_0337_8 crossref_primary_10_1155_2019_8295054 crossref_primary_10_1024_0301_1526_a001085 crossref_primary_10_1016_j_atherosclerosis_2015_07_002 crossref_primary_10_1007_s00380_018_1210_9 crossref_primary_10_1016_j_ejim_2007_09_003 crossref_primary_10_1177_1538574415608269 crossref_primary_10_1016_S0104_4230_12_70248_8 crossref_primary_10_1111_j_1365_2796_2010_02322_x crossref_primary_10_1016_j_semerg_2012_06_010 crossref_primary_10_3390_ijms160511131 crossref_primary_10_1016_j_avsg_2009_08_013 crossref_primary_10_1016_j_ejvs_2023_06_018 crossref_primary_10_1007_s00104_023_01821_0 crossref_primary_10_1007_s15034_016_0783_6 crossref_primary_10_1016_j_jclinepi_2009_10_009 crossref_primary_10_1177_1358863X07079823 crossref_primary_10_1016_j_jvs_2009_04_055 crossref_primary_10_1024_0301_1526_a001096 crossref_primary_10_1111_j_1445_2197_2006_03902_x crossref_primary_10_1097_rmr_0b013e318159aaa2 crossref_primary_10_1177_17085381211053492 crossref_primary_10_1093_eurheartj_ehi644 crossref_primary_10_1186_1471_2261_11_39 crossref_primary_10_3238_PersKardio_2024_05_31_02 crossref_primary_10_1590_S0104_42302012000500011 crossref_primary_10_1177_154431671303700203 crossref_primary_10_18521_ktd_1439261 crossref_primary_10_1016_j_fmc_2015_02_021 crossref_primary_10_1016_S0003_3170_06_74959_8 crossref_primary_10_1016_j_ejim_2018_01_007 crossref_primary_10_1177_1358863X18807003 crossref_primary_10_1016_j_jacc_2015_12_049 crossref_primary_10_1024_0301_1526_a001068 crossref_primary_10_1007_s00117_016_0079_9 crossref_primary_10_1016_j_jvs_2010_07_010 crossref_primary_10_1002_ccd_23373 crossref_primary_10_1093_eurheartj_ehi636 crossref_primary_10_1016_j_acvfr_2011_01_033 crossref_primary_10_1177_0003319716638797 crossref_primary_10_1177_0003319710371614 crossref_primary_10_1038_s41598_018_32607_8 crossref_primary_10_1016_j_cjca_2010_12_029 crossref_primary_10_1007_s11789_007_0001_0 crossref_primary_10_1016_j_yasu_2008_03_014 crossref_primary_10_1007_s00772_020_00673_w crossref_primary_10_1016_j_jvs_2019_03_071 crossref_primary_10_1024_0301_1526_a000901 crossref_primary_10_4103_mjhs_mjhs_151_22 crossref_primary_10_1007_s40520_018_1095_6 crossref_primary_10_1016_S0025_7753_09_71749_X crossref_primary_10_1186_s12913_019_4477_3 crossref_primary_10_12687_phleb2368_4_2017 crossref_primary_10_1080_08941939_2019_1690600 crossref_primary_10_1097_HCO_0b013e328338c109 crossref_primary_10_5348_100062Z09ZB2021CR crossref_primary_10_1016_j_jvs_2005_11_050 crossref_primary_10_1093_gerona_glz047 crossref_primary_10_1161_STROKEAHA_109_559740 crossref_primary_10_1177_0141076814557301 crossref_primary_10_1111_j_1365_2796_2005_01536_x crossref_primary_10_5999_aps_2012_39_3_227 crossref_primary_10_1016_j_jvs_2011_09_001 crossref_primary_10_2310_6670_2006_00017 crossref_primary_10_1016_j_avsg_2013_01_020 crossref_primary_10_1111_j_1475_097X_2007_00720_x crossref_primary_10_1016_j_jvs_2021_01_066 crossref_primary_10_1007_s00772_010_0831_9 crossref_primary_10_1186_1471_2482_8_22 crossref_primary_10_1007_s00059_020_04896_1 crossref_primary_10_1007_s00392_009_0754_1 crossref_primary_10_1186_1471_2261_11_4 crossref_primary_10_1016_j_apmr_2007_09_040 crossref_primary_10_3238_arztebl_m2022_0331 crossref_primary_10_18087_cardio_2021_3_n1498 crossref_primary_10_1016_j_foot_2012_08_008 crossref_primary_10_1016_j_jstrokecerebrovasdis_2011_04_006 crossref_primary_10_1159_000091087 crossref_primary_10_1159_000351720 crossref_primary_10_1002_ccd_24391 crossref_primary_10_1161_CIRCOUTCOMES_109_868505 crossref_primary_10_1053_j_semvascsurg_2022_05_003 crossref_primary_10_1080_00015458_2019_1586395 crossref_primary_10_1291_hypres_29_23 crossref_primary_10_1177_1534734620951528 crossref_primary_10_1016_j_cpcardiol_2014_05_003 crossref_primary_10_2217_ica_11_38 crossref_primary_10_1097_HJH_0b013e32832f4f54 crossref_primary_10_1177_1538574406296209 crossref_primary_10_1007_s00125_006_0587_7 crossref_primary_10_1038_s41598_023_48602_7 crossref_primary_10_1371_journal_pone_0244851 crossref_primary_10_3390_jcm13072141 crossref_primary_10_4137_CMC_S15230 crossref_primary_10_1177_1358863X08094800 crossref_primary_10_1016_j_jvs_2023_01_208 crossref_primary_10_1002_ccd_20906 crossref_primary_10_1016_j_ejvs_2014_12_027 crossref_primary_10_1016_j_ejvs_2023_08_067 crossref_primary_10_1007_s11883_011_0196_x crossref_primary_10_1016_j_zefq_2009_06_005 crossref_primary_10_1007_s00772_013_1235_4 crossref_primary_10_1583_13_4275MR_1 crossref_primary_10_1097_MD_0000000000035285 crossref_primary_10_1148_radiol_2533081627 crossref_primary_10_1016_j_ahj_2005_01_008 crossref_primary_10_1155_2011_316496 crossref_primary_10_1002_gps_2351 crossref_primary_10_1007_s00772_024_01086_9 crossref_primary_10_1016_j_suc_2023_04_015 crossref_primary_10_1007_s11789_007_0007_7 crossref_primary_10_1016_j_ejvs_2023_01_026 crossref_primary_10_15829_1728_8800_2013_2_63_69 crossref_primary_10_1093_ejcts_ezad426 crossref_primary_10_1191_1358863x05vm635oa crossref_primary_10_1007_s00772_023_00984_8 crossref_primary_10_4103_dmr_dmr_4_21 crossref_primary_10_1016_S1166_4568_09_45142_8 crossref_primary_10_1016_j_jss_2007_03_022 crossref_primary_10_1016_j_vasdi_2025_01_126 crossref_primary_10_1007_s00772_013_1269_7 crossref_primary_10_1583_08_2366_1 crossref_primary_10_1111_ijcp_13253 crossref_primary_10_1007_s11845_011_0779_0 crossref_primary_10_1161_CIRCULATIONAHA_107_726299 crossref_primary_10_1007_s00772_016_0234_7 crossref_primary_10_1007_s12262_016_1570_2 crossref_primary_10_1024_0301_1526_a001126 crossref_primary_10_1007_s15027_014_0360_7 crossref_primary_10_1016_j_arteri_2010_03_008 crossref_primary_10_1097_TGR_0b013e31828aa41a crossref_primary_10_1157_13094431 crossref_primary_10_3390_medicina60010147 crossref_primary_10_1016_j_ahj_2024_06_010 crossref_primary_10_1016_S1078_5884_11_60011_7 crossref_primary_10_1111_j_1540_8159_2008_01100_x crossref_primary_10_1177_15347346231212782 crossref_primary_10_1016_j_ccl_2010_08_003 crossref_primary_10_1186_s12912_020_00467_1 crossref_primary_10_1007_s40664_021_00452_8 crossref_primary_10_1016_j_ejvs_2023_08_005 crossref_primary_10_1177_1358863X11424312 crossref_primary_10_1016_S0003_3170_08_05001_3 crossref_primary_10_1161_CIRCULATIONAHA_105_605717 crossref_primary_10_1080_08037051_2017_1400903 crossref_primary_10_1016_j_jvs_2008_12_070 crossref_primary_10_1185_030079904X12780 crossref_primary_10_1007_s11789_007_0008_6 crossref_primary_10_1007_s40531_020_00040_0 crossref_primary_10_3390_jcm10050947 crossref_primary_10_1016_j_avsg_2010_09_013 crossref_primary_10_1016_j_ejvs_2023_01_002 crossref_primary_10_1111_ijcp_12148 crossref_primary_10_1007_s00772_013_1268_8 crossref_primary_10_1177_1358863X12445102 crossref_primary_10_1002_sim_9681 crossref_primary_10_3348_kjr_2010_11_4_441 crossref_primary_10_1007_s00423_018_1689_7 crossref_primary_10_3109_02813432_2012_675564 crossref_primary_10_1161_CIRCOUTCOMES_111_964379 crossref_primary_10_1177_0003319712448248 crossref_primary_10_3389_fcvm_2019_00008 crossref_primary_10_1161_CIRCULATIONAHA_109_865600 crossref_primary_10_1007_s11298_014_0006_1 crossref_primary_10_1159_000381254 crossref_primary_10_1002_14651858_CD003285_pub2 crossref_primary_10_1007_s00391_009_0051_7 crossref_primary_10_1177_1358863X221096704 crossref_primary_10_1097_01_rli_0000262581_52315_ef crossref_primary_10_1007_s00482_009_0773_x crossref_primary_10_1016_S1636_5410_23_47955_X crossref_primary_10_1053_j_semvascsurg_2022_04_006 crossref_primary_10_1053_j_semvascsurg_2022_04_005 crossref_primary_10_1016_j_jmv_2015_03_001 crossref_primary_10_1007_s00392_010_0240_9 crossref_primary_10_3390_microorganisms10102065 crossref_primary_10_1016_j_jvs_2007_02_004 crossref_primary_10_1016_j_hlc_2018_04_292 crossref_primary_10_1016_j_ejim_2011_08_004 crossref_primary_10_1373_clinchem_2012_193656 crossref_primary_10_1016_j_jvs_2009_05_061 crossref_primary_10_1097_AJP_0b013e3182340c01 crossref_primary_10_1016_j_arteri_2010_04_001 crossref_primary_10_1177_153857440403800609 crossref_primary_10_1016_j_atherosclerosis_2005_07_022 crossref_primary_10_1016_j_ejvs_2005_06_008 crossref_primary_10_1007_s00772_013_1267_9 crossref_primary_10_1016_j_jvn_2013_09_002 crossref_primary_10_1024_0301_1526_a001041 crossref_primary_10_1161_HYPERTENSIONAHA_113_02094 crossref_primary_10_1016_j_jvs_2016_07_119 crossref_primary_10_3945_jn_114_204594 crossref_primary_10_1097_01_hjr_0000183912_05484_8f crossref_primary_10_1007_s00330_008_1168_6 crossref_primary_10_1016_j_jvs_2008_05_072 crossref_primary_10_1161_CIRCULATIONAHA_105_607846 crossref_primary_10_1007_s00415_009_5017_6 crossref_primary_10_1185_03007990902860325 crossref_primary_10_1016_j_angio_2017_02_001 crossref_primary_10_3390_jcm10102048 crossref_primary_10_1016_j_avsg_2010_07_016 crossref_primary_10_1111_joic_12431 crossref_primary_10_1016_j_atherosclerosis_2009_11_016 crossref_primary_10_1007_s00108_017_0272_6 crossref_primary_10_1024_0301_1526_a001055 crossref_primary_10_1016_S0304_5412_09_73013_6 crossref_primary_10_7759_cureus_52019 crossref_primary_10_1007_s15006_014_3095_6 crossref_primary_10_1016_j_ejvs_2015_04_009 crossref_primary_10_1038_srep09937 crossref_primary_10_1016_j_ejvs_2009_04_013 crossref_primary_10_1016_j_ejvs_2021_05_016 crossref_primary_10_54912_jci_2023_0019 crossref_primary_10_1007_s00392_015_0834_3 crossref_primary_10_1111_iwj_13407 crossref_primary_10_1016_j_jvsv_2022_05_013 crossref_primary_10_1016_S1636_5410_13_65898_5 crossref_primary_10_1097_EDE_0000000000001630 crossref_primary_10_3389_fcvm_2022_1032755 crossref_primary_10_1016_j_ejim_2010_07_019 crossref_primary_10_1007_s00772_012_1010_y crossref_primary_10_1007_s11428_014_1296_3 crossref_primary_10_1179_joc_2006_18_1_103 crossref_primary_10_1016_j_jvs_2010_05_105 crossref_primary_10_1177_20420188211000504 crossref_primary_10_1055_a_1535_2774 crossref_primary_10_1177_2047487313519344 crossref_primary_10_1016_j_atherosclerosis_2006_08_006 crossref_primary_10_1007_s15027_016_0749_6 crossref_primary_10_1186_1471_2261_6_33 crossref_primary_10_3400_avd_oa_12_00003 crossref_primary_10_1093_eurheartj_eht142 crossref_primary_10_1016_j_hipert_2011_12_001 crossref_primary_10_20996_1819_6446_2021_02_10 crossref_primary_10_1259_dmfr_20180432 crossref_primary_10_1097_01_RVI_0000137978_15352_C6 crossref_primary_10_1161_CIRCRESAHA_115_306884 |
Cites_doi | 10.1161/01.ATV.18.2.185 10.1177/1358836X0100600204 10.1161/01.CIR.71.3.516 10.1093/ije/25.6.1172 10.1016/0021-9150(91)90014-T 10.1161/01.CIR.88.2.819 10.1093/ije/25.2.282 10.1001/jama.286.11.1317 10.1053/ejvs.1999.0843 10.1161/01.CIR.82.6.1925 10.1161/01.CIR.101.1.e16 10.1056/NEJM199202063260605 10.1016/S0140-6736(96)09457-3 10.1177/1358863X9600100112 10.1161/01.CIR.88.3.837 10.1001/archinte.159.4.387 10.1001/archinte.163.8.884 10.1002/bjs.1800560910 10.7326/0003-4819-136-12-200206180-00008 10.1001/archinte.163.8.877 10.1161/01.ATV.19.3.538 10.1016/S0140-6736(01)06351-6 |
ContentType | Journal Article |
Copyright | 2003 Elsevier Ireland Ltd 2004 INIST-CNRS |
Copyright_xml | – notice: 2003 Elsevier Ireland Ltd – notice: 2004 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/S0021-9150(03)00204-1 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EndPage | 105 |
ExternalDocumentID | 14709362 15383525 10_1016_S0021_9150_03_00204_1 S0021915003002041 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Europe Germany |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEIPS AEKER AENEX AEUPX AEVXI AEXQZ AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B M27 M41 MO0 N9A O-L O9- OAUVE OA~ OK1 OL0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K WUQ X7M Z5R ZGI ZXP ~G- ~KM AACTN AFCTW AFKWA AJOXV AMFUW NCXOZ RIG AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 EFLBG |
ID | FETCH-LOGICAL-c511t-7d86b39cb10af03298300d910d9210eac48b562e758fee3735f79b693971c4af3 |
IEDL.DBID | AIKHN |
ISSN | 0021-9150 |
IngestDate | Fri Sep 05 13:10:22 EDT 2025 Wed Feb 19 02:33:13 EST 2025 Wed Apr 02 07:26:34 EDT 2025 Tue Jul 01 04:07:53 EDT 2025 Thu Apr 24 22:57:22 EDT 2025 Tue Feb 04 22:31:28 EST 2025 Tue Aug 26 20:39:46 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Prevalence Ankle brachial index Peripheral arterial disease Cross-sectional study Atherothrombosis Primary care Epidemiology Doppler ultrasound study Claudication Systolic pressure Diastolic pressure Ankle brachial index: Primary care: Prevalence Cardiovascular disease Vascular disease Arterial disease Body mass index Intermittent Atherosclerosis Cerebrovascular disease Sonography Human Hypertension Nervous system diseases General practitioner Morbidity Cerebral disorder Arteriopathy Central nervous system disease Risk factor |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c511t-7d86b39cb10af03298300d910d9210eac48b562e758fee3735f79b693971c4af3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 14709362 |
PQID | 80083684 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_80083684 pubmed_primary_14709362 pascalfrancis_primary_15383525 crossref_primary_10_1016_S0021_9150_03_00204_1 crossref_citationtrail_10_1016_S0021_9150_03_00204_1 elsevier_sciencedirect_doi_10_1016_S0021_9150_03_00204_1 elsevier_clinicalkey_doi_10_1016_S0021_9150_03_00204_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2004 2004-1-00 2004-Jan 20040101 |
PublicationDateYYYYMMDD | 2004-01-01 |
PublicationDate_xml | – year: 2004 text: 2004 |
PublicationDecade | 2000 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: Ireland |
PublicationTitle | Atherosclerosis |
PublicationTitleAlternate | Atherosclerosis |
PublicationYear | 2004 |
Publisher | Elsevier Ireland Ltd Elsevier |
Publisher_xml | – name: Elsevier Ireland Ltd – name: Elsevier |
References | McDermott, Mehta, Greenland (BIB8) 1999; 159 Dormandy, Rutherford (BIB2) 2000; 31 Meijer, Hoes, Rutgers (BIB19) 1998; 18 Pittrow D, Wittchen HU, Kirch W. Hypertension and diabetes care among primary care doctors in Germany: results from an epidemiological cross-sectional study. In: Public Health in Europe. Kirch W, editor. Springer Verlag, Heidelberg, Germany, 2003. Hirsch, Halverson, Treat-Jacobson (BIB27) 2001; 6 Kaiser, Kester, Stoffers (BIB13) 1999; 18 Criqui, Fronek, Klauber (BIB9) 1985; 71 Yao, Hobbs, Irvine (BIB14) 1969; 56 Smith, Shipley, Rose (BIB5) 1990; 82 Orchard, Strandness (BIB12) 1993; 88 CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329–39. Federal Statistical Office. Statistical Yearbook 2001 for the Federal Republic of Germany. Metzler-Poeschel, Stuttgart, 2001. Halperin, Fuster (BIB29) 2003; 163 The getABI Study Group. The German Epidemiological Trial on Ankle Brachial Index (getABI): rationale, design and methods. VASA 2002;4:241–8. Arbeitsgruppe Epidemiologische Methoden der Deutschen Arbeitsgemeinschaft Epidemiologie (DAE). Leitlinen und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP). February 2000. Available: http://www.gmds.de/texte/onlinedocs/empfehlungen/empL.gep.langfassung.htm Stoffers, Rinkens, Kester (BIB24) 1996; 25 Hirsch, Criqui, Treat-Jacobson (BIB26) 2001; 286 Rose (BIB18) 1962; 27 Criqui, Langer, Fronek (BIB3) 1992; 326 Newman, Shemanski, Manolio (BIB25) 1999; 19 Greenland, Abrams, Aurigemma (BIB11) 2000; 101 Criqui, Denenberg, Bird (BIB10) 1996; 1 Belch, Topol, Agnelli, Bertrand, Califf, Clement (BIB28) 2003; 163 Ouriel (BIB1) 2001; 358 Newman, Siscovick, Manolio (BIB7) 1993; 88 McKenna, Wolfson, Kuller (BIB4) 1991; 87 Olin JW. The clinical evaluation and office based detection of peripheral arterial disease. In: Hirsch AT, Olin FW, eds. An office-based approach to the diagnosis and treatment of peripheral arterial disease. Am J Med (Continuing Education Series) 1998:10–7. Leng, Lee, Fowkes (BIB6) 1996; 25 McDermott, Greenland, Liu (BIB21) 2002; 136 Newman (10.1016/S0021-9150(03)00204-1_BIB25) 1999; 19 McKenna (10.1016/S0021-9150(03)00204-1_BIB4) 1991; 87 Greenland (10.1016/S0021-9150(03)00204-1_BIB11) 2000; 101 Belch (10.1016/S0021-9150(03)00204-1_BIB28) 2003; 163 Rose (10.1016/S0021-9150(03)00204-1_BIB18) 1962; 27 Orchard (10.1016/S0021-9150(03)00204-1_BIB12) 1993; 88 Criqui (10.1016/S0021-9150(03)00204-1_BIB9) 1985; 71 Smith (10.1016/S0021-9150(03)00204-1_BIB5) 1990; 82 Hirsch (10.1016/S0021-9150(03)00204-1_BIB26) 2001; 286 10.1016/S0021-9150(03)00204-1_BIB16 Kaiser (10.1016/S0021-9150(03)00204-1_BIB13) 1999; 18 10.1016/S0021-9150(03)00204-1_BIB15 McDermott (10.1016/S0021-9150(03)00204-1_BIB8) 1999; 159 10.1016/S0021-9150(03)00204-1_BIB17 Ouriel (10.1016/S0021-9150(03)00204-1_BIB1) 2001; 358 Criqui (10.1016/S0021-9150(03)00204-1_BIB3) 1992; 326 Criqui (10.1016/S0021-9150(03)00204-1_BIB10) 1996; 1 Yao (10.1016/S0021-9150(03)00204-1_BIB14) 1969; 56 10.1016/S0021-9150(03)00204-1_BIB20 Stoffers (10.1016/S0021-9150(03)00204-1_BIB24) 1996; 25 10.1016/S0021-9150(03)00204-1_BIB23 10.1016/S0021-9150(03)00204-1_BIB22 Newman (10.1016/S0021-9150(03)00204-1_BIB7) 1993; 88 Halperin (10.1016/S0021-9150(03)00204-1_BIB29) 2003; 163 Leng (10.1016/S0021-9150(03)00204-1_BIB6) 1996; 25 Dormandy (10.1016/S0021-9150(03)00204-1_BIB2) 2000; 31 Hirsch (10.1016/S0021-9150(03)00204-1_BIB27) 2001; 6 Meijer (10.1016/S0021-9150(03)00204-1_BIB19) 1998; 18 McDermott (10.1016/S0021-9150(03)00204-1_BIB21) 2002; 136 15186964 - Atherosclerosis. 2004 Jul;175(1):183-4; author reply 185-6 |
References_xml | – volume: 88 start-page: 837 year: 1993 end-page: 845 ident: BIB7 article-title: Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group publication-title: Circulation – volume: 31 start-page: S1 year: 2000 end-page: S296 ident: BIB2 article-title: Management of peripheral arterial disease (PAD). TASC Working Group publication-title: J. Vasc. Surg. – volume: 56 start-page: 676 year: 1969 end-page: 679 ident: BIB14 article-title: Ankle systolic pressure measurements in arterial disease affecting the lower extremities publication-title: Br. J. Surg. – volume: 71 start-page: 516 year: 1985 end-page: 522 ident: BIB9 article-title: The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from non-invasive testing in a defined population publication-title: Circulation – volume: 163 start-page: 877 year: 2003 end-page: 878 ident: BIB29 article-title: Meeting the challenge of peripheral arterial disease publication-title: Arch. Intern. Med. – reference: Arbeitsgruppe Epidemiologische Methoden der Deutschen Arbeitsgemeinschaft Epidemiologie (DAE). Leitlinen und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP). February 2000. Available: http://www.gmds.de/texte/onlinedocs/empfehlungen/empL.gep.langfassung.htm – reference: The getABI Study Group. The German Epidemiological Trial on Ankle Brachial Index (getABI): rationale, design and methods. VASA 2002;4:241–8. – volume: 18 start-page: 185 year: 1998 end-page: 192 ident: BIB19 article-title: Peripheral arterial disease in the elderly: The Rotterdam Study publication-title: Arterioscler. Thromb. Vasc. Biol. – reference: Pittrow D, Wittchen HU, Kirch W. Hypertension and diabetes care among primary care doctors in Germany: results from an epidemiological cross-sectional study. In: Public Health in Europe. Kirch W, editor. Springer Verlag, Heidelberg, Germany, 2003. – reference: Federal Statistical Office. Statistical Yearbook 2001 for the Federal Republic of Germany. Metzler-Poeschel, Stuttgart, 2001. – volume: 286 start-page: 1317 year: 2001 end-page: 1324 ident: BIB26 article-title: Peripheral arterial disease detection, awareness, and treatment in primary care publication-title: J. Am. Med. Assoc. – reference: Olin JW. The clinical evaluation and office based detection of peripheral arterial disease. In: Hirsch AT, Olin FW, eds. An office-based approach to the diagnosis and treatment of peripheral arterial disease. Am J Med (Continuing Education Series) 1998:10–7. – volume: 25 start-page: 282 year: 1996 end-page: 290 ident: BIB24 article-title: The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease publication-title: Int. J. Epidemiol. – volume: 18 start-page: 25 year: 1999 end-page: 29 ident: BIB13 article-title: The influence of experience on the reproducibility of the ankle-brachial systolic pressure ratio in peripheral arterial occlusive disease publication-title: Eur. J. Vasc. Endovasc. Surg. – volume: 6 start-page: 87 year: 2001 end-page: 96 ident: BIB27 article-title: The Minnesota Regional Peripheral Arterial Disease Screening Program: towards a definition of community standards of care publication-title: Vasc. Med. – volume: 87 start-page: 119 year: 1991 end-page: 128 ident: BIB4 article-title: The ratio of ankle and arm arterial pressure as an independent predictor of mortality publication-title: Atherosclerosis – volume: 101 start-page: E16 year: 2000 end-page: E22 ident: BIB11 article-title: Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: non-invasive tests of atherosclerotic burden: Writing Group III publication-title: Circulation – volume: 88 start-page: 819 year: 1993 end-page: 828 ident: BIB12 article-title: Assessment of peripheral vascular disease in diabetes: report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association, 18–20 September, 1992 New Orleans, Louisiana publication-title: Circulation – volume: 358 start-page: 1257 year: 2001 end-page: 1264 ident: BIB1 article-title: Peripheral arterial disease publication-title: Lancet – volume: 19 start-page: 538 year: 1999 end-page: 545 ident: BIB25 article-title: Ankle–arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 25 start-page: 1172 year: 1996 end-page: 1181 ident: BIB6 article-title: Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population publication-title: Int. J. Epidemiol. – volume: 136 start-page: 873 year: 2002 end-page: 883 ident: BIB21 article-title: The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study publication-title: Ann. Intern. Med. – volume: 326 start-page: 381 year: 1992 end-page: 386 ident: BIB3 article-title: Mortality over a period of 10 years in patients with peripheral arterial disease publication-title: N. Engl. J. Med. – volume: 82 start-page: 1925 year: 1990 end-page: 1931 ident: BIB5 article-title: Intermittent claudication, heart disease risk factors, and mortality: the Whitehall Study publication-title: Circulation – volume: 159 start-page: 387 year: 1999 end-page: 392 ident: BIB8 article-title: Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease publication-title: Arch. Intern. Med. – volume: 163 start-page: 884 year: 2003 end-page: 892 ident: BIB28 article-title: Critical issues in peripheral arterial disease detection and management: a call to action publication-title: Arch. Intern. Med. – reference: CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329–39. – volume: 1 start-page: 65 year: 1996 end-page: 71 ident: BIB10 article-title: The correlation between symptoms and non- invasive test results in patients referred for peripheral arterial disease testing publication-title: Vasc. Med. – volume: 27 start-page: 645 year: 1962 end-page: 658 ident: BIB18 article-title: The diagnosis of ischaemic heart pain and intermittent claudication in field surveys publication-title: Bull. World Health Organ. – volume: 18 start-page: 185 year: 1998 ident: 10.1016/S0021-9150(03)00204-1_BIB19 article-title: Peripheral arterial disease in the elderly: The Rotterdam Study publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.18.2.185 – volume: 6 start-page: 87 year: 2001 ident: 10.1016/S0021-9150(03)00204-1_BIB27 article-title: The Minnesota Regional Peripheral Arterial Disease Screening Program: towards a definition of community standards of care publication-title: Vasc. Med. doi: 10.1177/1358836X0100600204 – ident: 10.1016/S0021-9150(03)00204-1_BIB22 – volume: 71 start-page: 516 issue: 3 year: 1985 ident: 10.1016/S0021-9150(03)00204-1_BIB9 article-title: The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from non-invasive testing in a defined population publication-title: Circulation doi: 10.1161/01.CIR.71.3.516 – volume: 25 start-page: 1172 year: 1996 ident: 10.1016/S0021-9150(03)00204-1_BIB6 article-title: Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population publication-title: Int. J. Epidemiol. doi: 10.1093/ije/25.6.1172 – volume: 87 start-page: 119 year: 1991 ident: 10.1016/S0021-9150(03)00204-1_BIB4 article-title: The ratio of ankle and arm arterial pressure as an independent predictor of mortality publication-title: Atherosclerosis doi: 10.1016/0021-9150(91)90014-T – volume: 88 start-page: 819 year: 1993 ident: 10.1016/S0021-9150(03)00204-1_BIB12 article-title: Assessment of peripheral vascular disease in diabetes: report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association, 18–20 September, 1992 New Orleans, Louisiana publication-title: Circulation doi: 10.1161/01.CIR.88.2.819 – ident: 10.1016/S0021-9150(03)00204-1_BIB20 – volume: 27 start-page: 645 year: 1962 ident: 10.1016/S0021-9150(03)00204-1_BIB18 article-title: The diagnosis of ischaemic heart pain and intermittent claudication in field surveys publication-title: Bull. World Health Organ. – volume: 25 start-page: 282 year: 1996 ident: 10.1016/S0021-9150(03)00204-1_BIB24 article-title: The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease publication-title: Int. J. Epidemiol. doi: 10.1093/ije/25.2.282 – ident: 10.1016/S0021-9150(03)00204-1_BIB17 – volume: 31 start-page: S1 issue: 1 Pt. 2 year: 2000 ident: 10.1016/S0021-9150(03)00204-1_BIB2 article-title: Management of peripheral arterial disease (PAD). TASC Working Group publication-title: J. Vasc. Surg. – volume: 286 start-page: 1317 issue: 11 year: 2001 ident: 10.1016/S0021-9150(03)00204-1_BIB26 article-title: Peripheral arterial disease detection, awareness, and treatment in primary care publication-title: J. Am. Med. Assoc. doi: 10.1001/jama.286.11.1317 – volume: 18 start-page: 25 issue: 1 year: 1999 ident: 10.1016/S0021-9150(03)00204-1_BIB13 article-title: The influence of experience on the reproducibility of the ankle-brachial systolic pressure ratio in peripheral arterial occlusive disease publication-title: Eur. J. Vasc. Endovasc. Surg. doi: 10.1053/ejvs.1999.0843 – volume: 82 start-page: 1925 year: 1990 ident: 10.1016/S0021-9150(03)00204-1_BIB5 article-title: Intermittent claudication, heart disease risk factors, and mortality: the Whitehall Study publication-title: Circulation doi: 10.1161/01.CIR.82.6.1925 – ident: 10.1016/S0021-9150(03)00204-1_BIB23 – volume: 101 start-page: E16 issue: 1 year: 2000 ident: 10.1016/S0021-9150(03)00204-1_BIB11 article-title: Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: non-invasive tests of atherosclerotic burden: Writing Group III publication-title: Circulation doi: 10.1161/01.CIR.101.1.e16 – volume: 326 start-page: 381 year: 1992 ident: 10.1016/S0021-9150(03)00204-1_BIB3 article-title: Mortality over a period of 10 years in patients with peripheral arterial disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199202063260605 – ident: 10.1016/S0021-9150(03)00204-1_BIB15 doi: 10.1016/S0140-6736(96)09457-3 – volume: 1 start-page: 65 issue: 1 year: 1996 ident: 10.1016/S0021-9150(03)00204-1_BIB10 article-title: The correlation between symptoms and non- invasive test results in patients referred for peripheral arterial disease testing publication-title: Vasc. Med. doi: 10.1177/1358863X9600100112 – volume: 88 start-page: 837 issue: 3 year: 1993 ident: 10.1016/S0021-9150(03)00204-1_BIB7 article-title: Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group publication-title: Circulation doi: 10.1161/01.CIR.88.3.837 – volume: 159 start-page: 387 issue: 4 year: 1999 ident: 10.1016/S0021-9150(03)00204-1_BIB8 article-title: Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease publication-title: Arch. Intern. Med. doi: 10.1001/archinte.159.4.387 – volume: 163 start-page: 884 year: 2003 ident: 10.1016/S0021-9150(03)00204-1_BIB28 article-title: Critical issues in peripheral arterial disease detection and management: a call to action publication-title: Arch. Intern. Med. doi: 10.1001/archinte.163.8.884 – volume: 56 start-page: 676 issue: 9 year: 1969 ident: 10.1016/S0021-9150(03)00204-1_BIB14 article-title: Ankle systolic pressure measurements in arterial disease affecting the lower extremities publication-title: Br. J. Surg. doi: 10.1002/bjs.1800560910 – volume: 136 start-page: 873 issue: 12 year: 2002 ident: 10.1016/S0021-9150(03)00204-1_BIB21 article-title: The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-136-12-200206180-00008 – ident: 10.1016/S0021-9150(03)00204-1_BIB16 – volume: 163 start-page: 877 year: 2003 ident: 10.1016/S0021-9150(03)00204-1_BIB29 article-title: Meeting the challenge of peripheral arterial disease publication-title: Arch. Intern. Med. doi: 10.1001/archinte.163.8.877 – volume: 19 start-page: 538 issue: 3 year: 1999 ident: 10.1016/S0021-9150(03)00204-1_BIB25 article-title: Ankle–arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.19.3.538 – volume: 358 start-page: 1257 year: 2001 ident: 10.1016/S0021-9150(03)00204-1_BIB1 article-title: Peripheral arterial disease publication-title: Lancet doi: 10.1016/S0140-6736(01)06351-6 – reference: 15186964 - Atherosclerosis. 2004 Jul;175(1):183-4; author reply 185-6 |
SSID | ssj0004718 |
Score | 2.3654926 |
Snippet | We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise.... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 95 |
SubjectTerms | Aged Aged, 80 and over Ankle - blood supply Ankle brachial index Arteriosclerosis - epidemiology Atherosclerosis (general aspects, experimental research) Atherothrombosis Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Comorbidity Cross-Sectional Studies Cross-sectional study Diabetic Angiopathies - epidemiology Epidemiology Female Germany - epidemiology Humans Male Medical sciences Peripheral arterial disease Peripheral Vascular Diseases - diagnostic imaging Peripheral Vascular Diseases - epidemiology Prevalence Primary care Primary Health Care Risk Factors Ultrasonography |
Title | High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0021915003002041 https://dx.doi.org/10.1016/S0021-9150(03)00204-1 https://www.ncbi.nlm.nih.gov/pubmed/14709362 https://www.proquest.com/docview/80083684 |
Volume | 172 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB3RRaoqVajfXWi3PnCgh0CcOE7MDaGihQpOReJm2YktrUST1e5y5bcz4zhEHBBVLzlYGsv2jGee45lngH0v6FFuopz1jUtEjh9Vc594w5uqsBaDDv3Qv7yS82txcVPcbMHpUAtDaZXR9_c-PXjr2HIUV_NouVhQjS_uNsQzaKZU4YlHoO0Mo301ge2T89_zq7E8suS9Q6ZsBBQYC3n6TkLjQZr_DP0k_LkQ9XZp1rhwvn_x4nlIGkLT2TvYiZiSnfTDfg9brv0Ary_jrflH2FAyB1uuiNmbJsg6z4jgODAK3LKQ1YlmyOJlDTNtw-ou-dut7KJBlM4WLZO4A7GLQE3BKF2MRUbW9TEL00jWIamLBhIoaz_B9dmvP6fzJL62kNQIujZJ2VTS5qq2PDU-zTNV4bo2iCYahcdC9M-isgiWHB4wvHN5mRe-VFYqBDS8Fsbnn2HSdq37CozLrCmKwpisdMJ5qbxXsjC1KosyS206BTEssK4jFTm9iHGrx5wz1Ismveg010Evmk_h8FEsTvglATloTw-FpugaNUaLlwSrR8En1vgvorMnZjKOFEMLcc9O4cdgNxq3Mt3PmNZ1d2tdER6WlZjCl96cRllRpgqhxu7_j2sP3vRJR_T36BtMNqs79x3x1MbO4NXhPZ_FXfMAZBUVmw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB6hIu0irdC-YAu74AMH9hBIGseJ94aqRWWhPYHEzbITW6oESdWW_8-M4xD1gEB7ycHSWH6MZz7HM98AnDhORbmJctZVNuIpfmSZuMjppCoyY9Dp0A_96UxM7vi_--x-C8ZdLgyFVQbb39p0b61Dy3lYzfPFfE45vnjaEM-gmlKGJ16BtjkVtR7A9sXV9WTWp0fmSWuQKRoBBfpEnrYT33gap799P1Hymov6tNArXDjXVrx4HZJ613T5GXYDpmQX7bC_wJatv8KHaXg1_wZrCuZgiyUxe9MEWeMYERx7RoEH5qM6UQ1ZeKxhuq5Y2USPzdLMK0TpbF4zgScQu_DUFIzCxVhgZF39YX4a0coHddFAPGXtd7i7_Hs7nkSh2kJUIuhaR3lVCJPK0iSxdnE6kgWua4VoopJ4LUT7zAuDYMniBcNZm-Zp5nJphERAk5Rcu3QPBnVT2x_AEjGqsizTepRbbp2QzkmR6VLmWT6KTTwE3i2wKgMVOVXEeFB9zBnui6J9UXGq_L6oZAhnL2Jhwm8JiG73VJdoiqZRobd4S7B4EdzQxveIHm2oST9SdC3EPTuE405vFB5lep_RtW2eVqogPCwKPoT9Vp16WZ7HEqHGwf-P6xg-Tm6nN-rmanZ9CDttABL9SfoJg_Xyyf5CbLU2R-HsPAPrTxeB |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+prevalence+of+peripheral+arterial+disease+and+co-morbidity+in+6880+primary+care+patients%3A+cross-sectional+study&rft.jtitle=Atherosclerosis&rft.au=DIEHM%2C+Curt&rft.au=SCHUSTER%2C+Alexander&rft.au=ALLENBERG%2C+Jens+R&rft.au=DARIUS%2C+Harald&rft.date=2004&rft.pub=Elsevier&rft.issn=0021-9150&rft.volume=172&rft.issue=1&rft.spage=95&rft.epage=105&rft_id=info:doi/10.1016%2FS0021-9150%2803%2900204-1&rft.externalDBID=n%2Fa&rft.externalDocID=15383525 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9150&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9150&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9150&client=summon |